SODIUM BICARBONATE injection, solution

Land: USA

Språk: engelsk

Kilde: NLM (National Library of Medicine)

Aktiv ingrediens:

Sodium Bicarbonate (UNII: 8MDF5V39QO) (BICARBONATE ION - UNII:HN1ZRA3Q20)

Tilgjengelig fra:

General Injectables & Vaccines, Inc.

INN (International Name):

Sodium Bicarbonate

Sammensetning:

Sodium Bicarbonate 75 mg in 1 mL

Administreringsrute:

INTRAVENOUS

Resept typen:

PRESCRIPTION DRUG

Indikasjoner:

Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydratin, extracorporeal circulation of blood, cardiac arrest and in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments.  Sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis-e.g., insulin in uncomplicated diabetes, blood volume restoration in shock.  But since an appreciable time interval may elapse before all of the ancillary effects are brought about, bicarbonate

Produkt oppsummering:

Sodium Bicarbonate Injection, USP is supplied in the following dosage forms: Store at 20 to 25o C (68 to 77o F) [See USP Controlled Room Temperature.] Revised: October, 2005 HOSPIRA, INC., LAKE FOREST, IL 60045 USA Abboject is a trademark of the Abbott group of companies. 

Autorisasjon status:

unapproved drug other

Preparatomtale

SODIUM BICARBONATE- SODIUM BICARBONATE INJECTION, SOLUTION
GENERAL INJECTABLES & VACCINES, INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
7.5% SODIUM BICARBONATE INJ. USP 50 ML
DESCRIPTION
Sodium Bicarbonate Injection, USP is a sterile, nonpyrogenic,
hypertonic solution of
sodium bicarbonate (NaHCO ) in water for injection for administration
by the
intravenous route as an electrolyte replenisher and systemic
alkalizer.
Solutions are offered in concentrations of 4.2%, 5.0%, 7.5% and 8.4%.
See table in
HOW SUPPLIED section for contents and characteristics.
Solution in LVP container has 0.9 mg/mL of edetate disodium anhydrous
added as a
stabilizer.
The solutions contain no bacteriostat, antimicrobial agent or added
buffer and are
intended only for use as a single-dose injection. When smaller doses
are required, the
unused portion should be discarded with the entire unit.
Sodium bicarbonate, 84 mg is equal to one milliequivalent each of Na+
and HCO -.
Sodium Bicarbonate, USP is chemically designated NaHCO
a white crystalline powder
soluble in water.
Water for injection, USP is chemically designated H O.
CLINICAL PHARMACOLOGY
Intravenous sodium bicarbonate therapy increases plasma bicarbonate,
buffers excess
hydrogen ion concentration, raises blood pH and reverses the clinical
manifestations of
acidosis.
Sodium bicarbonate in water dissociates to provide sodium (Na+) and
bicarbonate
(HCO3-) ions. Sodium (Na+) is the principal cation of the
extracellular fluid and plays a
large part in the therapy of fluid and electrolyte disturbances.
Bicarbonate (HCO3-)is a
normal constituent of body fluids and the normal plasma level ranges
from 24 to 31
mEq/liter. Plasma concentration is regulated by the kidney through
acidification of the
urine when there is a deficit or by alkalinization of the urine when
there is an excess.
Bicarbonate anion is considered "labile" since at a